Canopy Growth Implements Renewed Strategy As Revenue Climbs 22%

Canopy Growth Corporation CGC WEED disclosed its net revenue rose by 22% year over year, reaching CA$110 million (US$82 million) in the first quarter of fiscal 2021.

The revenue growth can be attributed to higher medical cannabis sales in Canada and Germany, as well as Storz & Bickel vaporizer sales and the full quarter contributions of its acquired businesses.

Canopy acquired German cannabis company C3 for $253 million, and This Works for about $74 million.

Canopy CEO David Klein said Monday they are "proud of our strong first-quarter performance, despite unprecedented volatility and uncertainty in the market and across the globe."

Canopy is implementing a "renewed corporate strategy" alongside a new leadership team, that way positioning its business for "continued growth," added Klein.

Moreover, over the quarter, the Smith Falls, Ontario-based company strengthened its position in the cannabis-infused beverage segment.

Canopy has been expanding its presence in the market, following the purchase of Ebbu, an infused technology company from Colorado, for $297 million in 2018.

Meantime, here's what the company's latest earnings report revealed:

  • Gross margin of 6%, a year-over-year decrease of 1,400 bps.
  • Adjusted gross margin (excluding inventory step-up costs) of 7%, a drop of 1,300 bps compared to the first quarter of fiscal 2020
  • Total SG&A expenses decreased by 23% over a year
  • Sales & Marketing expenses declined by 25% during the same period
  • G&A and R&D expenses rose by 2% and 61%, respectively
  • Net loss of $128 million, up by 34% compared to the same quarter last year
  • Negative adjusted EBITDA of CA$92 million, versus a loss of CA$93 million in the corresponding quarter of fiscal 2020
  • Cash and Short-term Investments were CA$2.0 billion
  • Canadian medical revenue rose 19% year-over-year
  • Recreational B2C and B2B net sales in Canada declined by 12% and 10%, respectively

Quarterly Highlights

Other quarterly highlights include the launching of e-commerce site ShopCanopy, expansion of S&B vaporizer product distribution in the U.S., and final preparations for the introduction of Martha Stewart branded health and wellness CBD products, to name a few.

Mike Lee, the company's CFO, explained they are "focused on further optimizing our operating footprint through a full end-to-end strategy that looks at people, process, technology, and infrastructure that we believe will lead to best in class margins over time." 

Courtesy photo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsM&ANewscannabis industrycannabis sales
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
Cannabis Conference Chicago 2024

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.